Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00074178
Brief Title: Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-B)

First Submitted : December 10, 2003
First Submitted that Met QC Criteria : December 10, 2003
First Posted : December 11, 2003 (Estimate)

Last Update Submitted that Met QC Criteria : April 19, 2017
Last Update Posted : April 21, 2017